These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Exploring the sounds of silence: RNAi-mediated gene silencing for target identification and validation.
    Author: Chatterjee-Kishore M, Miller CP.
    Journal: Drug Discov Today; 2005 Nov 15; 10(22):1559-65. PubMed ID: 16257379.
    Abstract:
    Drug development begins with the identification and early preclinical validation of novel biological targets, a process often called 'target identification and validation'. This process usually uses various approaches, such as observations from literature and findings from animal or clinical studies, together with cutting edge molecular techniques that include analyses of gene and protein expression, interaction and function. The publication of the human genome has increased research in gene and protein expression analysis that, in combination with RNA interference technology, promises the evaluation of novel functions for known genes, as well as hitherto unknown or unstudied genes with functions relevant to disease.
    [Abstract] [Full Text] [Related] [New Search]